BioAsia 2026 to kick off on February 17 with record participation

Asia’s premier life sciences and health-tech forum BioAsia will be inaugurated by Chief Minister A. Revanth Reddy alongside Industries Minister D. Sridhar Babu on February 17.

The two-day event is set to scale new heights in its 2026 edition, reflecting a sharp year-on-year rise in global participation and industry engagement. More than 4,000 delegates from across the world are expected to attend, strengthening Hyderabad’s position as a global hub for life sciences innovation, research and collaboration.

The 2025 edition hosted around 3,000 delegates. In contrast, the 2026 edition has drawn over 4,000 delegates and participation from more than 500 companies worldwide.

Themed ‘TechBio Unleashed: AI, Automation & the Biology Revolution’, BioAsia 2026 will spotlight the convergence of artificial intelligence, automation, and biological sciences. The event will feature over 175 exhibitors across pharmaceuticals, biotechnology, medtech, digital health and advanced manufacturing.

Specialised platforms curated to promote innovation and entrepreneurship include a Startup Pavilion with 40 emerging startups, an Innovation Pavilion featuring 16 exhibitors showcasing breakthrough technologies, and participation by 22 MSMEs, reflecting continued support for small and medium enterprises.

The conference will host keynote sessions by Bruce Levine, Howard Y. Chang and Pushmeet Kohli, with discussions centred on AI-driven drug discovery, advanced biomanufacturing, and next-generation therapeutic modalities.

Global pharmaceutical and life sciences majors such as Novartis, Eli Lilly, Thermo Fisher Scientific, Sanofi, MSD and Miltenyi Biotec will feature prominently, alongside Indian leaders including Dr. Reddy’s Laboratories and Biocon Biologics.